Erratum To: First-In-Human Phase I Study of SOR-C13, a TRPV6 Calcium Channel Inhibitor, in Patients With Advanced Solid Tumors
Investigational New Drugs - Netherlands
doi 10.1007/s10637-017-0455-y
Full Text
Open PDFAbstract
Available in full text
Date
April 7, 2017
Authors
Publisher
Springer Science and Business Media LLC